151 related articles for article (PubMed ID: 10072910)
1. Anti-inflammatory and ulcerogenic effects of 3-(N,N-diethylamino) propylindometacin HCl.
Huang ZL; Kagoshima M; Kagawa E; Wang WQ; Shimada H
Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):306-8. PubMed ID: 10072910
[TBL] [Abstract][Full Text] [Related]
2. Ulcerogenicity and effect on inhibition of prostaglandin generation of indometacin farnesil, a prodrug of indomethacin, in rat gastric mucosa: comparison with indomethacin or loxoprofen.
Arakawa T; Fukuda T; Nakagawa K; Higuchi K; Watanabe T; Tominaga K; Kobayashi K
Drugs Exp Clin Res; 1995; 21(3):85-8. PubMed ID: 7555616
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory, analgesic, and antipyretic effects and gastrointestinal toxicity of the new anti-inflammatory drug N-(3-[3-(piperidinylmethyl)phenoxy]propyl)-carbamoylmethylthio ]ethyl 1-(p-chlorobenzoyl) 5-methoxy-2-methyl-3-indolylacetate.
Segawa Y; Ohya O; Abe T; Omata T; Tsuzuike N; Itokazu Y; Yoshida K; Tagashira E; Ueda I
Arzneimittelforschung; 1992 Jul; 42(7):954-8. PubMed ID: 1418061
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterisation of the somatostatin analogue TT-232: effects on neurogenic and non-neurogenic inflammation and neuropathic hyperalgesia.
Pintér E; Helyes Z; Németh J; Pórszász R; Pethö G; Thán M; Kéri G; Horváth A; Jakab B; Szolcsányi J
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):142-50. PubMed ID: 12122501
[TBL] [Abstract][Full Text] [Related]
5. Ethanesulfohydroxamic acid ester prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs): synthesis, nitric oxide and nitroxyl release, cyclooxygenase inhibition, anti-inflammatory, and ulcerogenicity index studies.
Huang Z; Velázquez CA; Abdellatif KR; Chowdhury MA; Reisz JA; DuMond JF; King SB; Knaus EE
J Med Chem; 2011 Mar; 54(5):1356-64. PubMed ID: 21280601
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of some novel pyrazole derivatives as potential antiinflammatory agents with minimum ulcerogenic activity.
el-Hawash SA; el-Mallah AI
Pharmazie; 1998 Jun; 53(6):368-73. PubMed ID: 9675765
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of inflammation and gastric damage in rats by copper (II) complexes.
Jiménez-Hernández RM; Frechilla D; Lasheras B; Gutiérrez-Ríos MT; Parrondo E; Craciunescu G; Cenarruzabeita E
Arzneimittelforschung; 1995 Mar; 45(3):277-81. PubMed ID: 7741784
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of orally active prodrugs of indomethacin.
Bandgar BP; Sarangdhar RJ; Viswakarma S; Ahamed FA
J Med Chem; 2011 Mar; 54(5):1191-201. PubMed ID: 21284386
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological properties of the new non-steroidal anti-inflammatory agent etodolac.
Inoue K; Fujisawa H; Sasaki Y; Nishimura T; Nishimura I; Inoue Y; Yokota M; Masuda T; Ueda F; Shibata Y
Arzneimittelforschung; 1991 Mar; 41(3):228-35. PubMed ID: 1651085
[TBL] [Abstract][Full Text] [Related]
10. Anti inflammatory, analgesic, antiproteolytic and ulcerogenic activities of some new 1-[3-(aryloxy)-propyl]-diamines.
Dimitra HL
Res Commun Chem Pathol Pharmacol; 1993 Jul; 81(1):91-102. PubMed ID: 8210692
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory and gastro sparing activity of some new indomethacin derivatives.
Amir M; Kumar S
Arch Pharm (Weinheim); 2005 Jan; 338(1):24-31. PubMed ID: 15674801
[TBL] [Abstract][Full Text] [Related]
12. Comparative studies on the amino acid derivatives of indometacin.
Krupińska J; Mazur J; Piotrowicz J; Cebo B; Stephanus R
Pol J Pharmacol Pharm; 1986; 38(2):149-56. PubMed ID: 3092202
[TBL] [Abstract][Full Text] [Related]
13. A sulphonamido-indanone derivative CGP 28237 (ZK 34228), a novel non-steroidal anti-inflammatory agent without gastro-intestinal ulcerogenicity in rats.
Böttcher I; Schweizer A; Glatt M; Werner H
Drugs Exp Clin Res; 1987; 13(5):237-45. PubMed ID: 3500026
[TBL] [Abstract][Full Text] [Related]
14. IDPH-8261--a new nonsteroidal antiinflammatory agent.
Rao CS; Singh PP; Junnarkar AY; Muralidhar N; Trivedi BS; Rao BE
Indian J Exp Biol; 1995 Jan; 33(1):28-33. PubMed ID: 9135671
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory potential of thienopyridines as possible alternative to NSAIDs.
Madhusudana K; Shireesha B; Naidu VG; Ramakrishna S; Narsaiah B; Rao AR; Diwan PV
Eur J Pharmacol; 2012 Mar; 678(1-3):48-54. PubMed ID: 22209879
[TBL] [Abstract][Full Text] [Related]
16. Acute and chronic anti-inflammatory properties of [2,2-dimethyl-6-(4- chlorophenyl)-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl]-acetic acid.
Laufer S; Tries S; Augustin J; Elsässer R; Albrecht W; Guserle R; Algate DR; Atterson PR; Munt PL
Arzneimittelforschung; 1995 Jan; 45(1):27-32. PubMed ID: 7893265
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological properties of the antiinflammatory agent 10-methylamine-11-H-indeno-[1,2-b]quinolin-11-one (MB432).
Chojnacka-Wójcik E; Naparzewska A
Pol J Pharmacol Pharm; 1983; 35(4):327-32. PubMed ID: 6607462
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory and antinociceptive properties of BP 2-94, a histamine H(3)-receptor agonist prodrug.
Rouleau A; Stark H; Schunack W; Schwartz JC
J Pharmacol Exp Ther; 2000 Oct; 295(1):219-25. PubMed ID: 10991982
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory and immunomodulating effects of the novel agent gamma-(2-aminoethylamino)-2-butyrothienone. 1st communication: inhibitory effects on mouse paw edema.
Gavalas A; Kourounakis L; Litina D; Kourounakis P
Arzneimittelforschung; 1991 Apr; 41(4):423-6. PubMed ID: 1859517
[TBL] [Abstract][Full Text] [Related]
20. Alkyl ester prodrugs for improved topical delivery of ibuprofen.
Bansal AK; Khar RK; Dubey R; Sharma AK
Indian J Exp Biol; 2001 Mar; 39(3):280-3. PubMed ID: 11495290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
